Welcome to our dedicated page for W.R Berkley SEC filings (Ticker: WRB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The W. R. Berkley Corporation (WRB) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. W. R. Berkley is a Delaware-incorporated insurance holding company whose common stock trades on the New York Stock Exchange under the symbol WRB, alongside several series of subordinated debentures listed under symbols such as WRB-PE, WRB-PF, WRB-PG, and WRB-PH, as noted in its Form 8-K filings.
Through this page, users can review current reports on Form 8-K in which W. R. Berkley reports material events. Recent 8-K filings referenced in the supplied data include announcements of quarterly results, where the company incorporates its earnings press releases by reference, and an 8-K describing Mitsui Sumitomo Insurance Co., Ltd.’s acquisition of beneficial ownership of a portion of W. R. Berkley’s outstanding common stock. These filings also confirm key details such as the company’s jurisdiction of incorporation and the listing of its securities on the New York Stock Exchange.
In addition to 8-Ks, investors typically look to annual reports on Form 10-K and quarterly reports on Form 10-Q for information on segment performance, underwriting results, investment income, risk factors, and capital structure. While those specific forms are not reproduced in the provided text, they are part of the company’s broader SEC reporting framework referenced in its Safe Harbor statements, which direct readers to risks and uncertainties detailed in its SEC filings.
Stock Titan enhances access to these documents with AI-powered summaries that help explain the key points in lengthy filings, highlight important items such as segment results and capital actions, and make it easier to understand complex disclosures. Users can also monitor filings related to the company’s listed debt securities and any future insider transaction reports on Form 4, all in one place with real-time updates from the EDGAR system.
W.R. Berkley insider report: The filing shows that William R. Berkley Jr. had performance-based restricted stock units (RSUs) vest on 08/15/2025, resulting in 111,869 shares issued from grants made in 2020, 2021 and 2022 tied to the three-year performance period ending June 30, 2025. To cover taxes, 4,696 shares were withheld/sold at $71.235, leaving Mr. Berkley Jr. with 4,552,770 shares directly beneficially owned. The filing also reports indirect holdings: 67,069,033 shares held by WR Berkley & Others LLC and 1,350,000 shares held by the 2011 GST Trust, reflecting the reporting person and Mr. William R. Berkley as majority beneficial owners of the LLC.
William R. Berkley, Executive Chairman and director of W. R. Berkley Corporation (WRB), reported transactions dated 08/15/2025 reflecting the vesting of performance-based restricted stock units (RSUs) and a tax-withholding sale. A total of 111,869 shares vested from grants made in 2020–2022, increasing his direct holdings to 17,367,562 shares before withholding. The company withheld 4,277 shares to satisfy tax obligations at a reported price of $71.235 per share, leaving 17,363,285 shares directly held after the withholding. The filing also discloses substantial indirect holdings: 67,069,033 shares via WR Berkley & Others LLC, 1,350,000 shares via the 2011 GST Trust, and 204,364 shares held by the reporting person’s spouse. The form was signed on 08/19/2025.
BERKLEY W R CORP filed a Form 13F reporting its institutional holdings. The report lists 227 positions with a combined market value of $1,906,688,792. The report is signed by Richard M. Baio, Executive Vice President & Chief Financial Officer, dated 08-14-2025.
W.R. Berkley Corp. (WRB) – Form 144 filing: An insider has filed notice to sell up to 53,375 common shares through J.P. Morgan Securities on or about 28 Jul 2025 on the NYSE. The shares carry an aggregate market value of roughly $3.67 million. With 379.36 million shares outstanding, the planned disposition equals only ~0.014 % of total shares, indicating limited dilution or price impact.
- Stock was acquired via equity-compensation grants made annually from 2017-2024.
- No sales have been recorded by this filer during the past three months.
- The filer certifies possession of no undisclosed adverse information.
The Form 144 is a preliminary notice; the trade may or may not be executed, but it signals a modest insider liquidity event that investors may monitor for sentiment cues.